http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
ORIGIN AND STATUS OF LOW-MASS CANDIDATE HYPERVELOCITY STARS
Bum-Suk Yeom,이영선,구재림,Timothy C. Beers,김영광 한국천문학회 2019 Journal of The Korean Astronomical Society Vol.52 No.3
We present an analysis of the chemical abundances and kinematics of six low-mass dwarf stars, previously claimed to be candidate hypervelocity stars (HVSs). We obtained moderate-resolution ($R\sim6000$) spectra of these stars to estimate the abundances of several chemical elements (Mg, Si, Ca, Ti, Cr, Fe, and Ni), and derived their space velocities and orbital parameters using proper motions from the \gaia\ Data Release 2. All six stars are shown to be bound to the Milky Way, and in fact are not even considered high-velocity stars with respect to the Galactic rest frame. Nevertheless, we attempt to characterize their parent Galactic stellar components by simultaneously comparing their element abundance patterns and orbital parameters with those expected from various Galactic stellar components. We find that two of our program stars are typical disk stars. For four stars, even though their kinematic probabilistic membership assignment suggests membership in the Galactic disk, based on their distinct orbit l properties and chemical characteristics, we cannot rule out exotic origins as follows. Two stars may be runaway stars from the Galactic disk. One star has possibly been accreted from a disrupted dwarf galaxy or dynamically heated from a birthplace in the Galactic bulge. The last object may be either a runaway disk star or has been dynamically heated. Spectroscopic follow-up observations with higher resolution for these curious objects will provide a better understanding of their origin.
Choi Won Suk,Song Joon Young,Kwon Ki Tae,Lee Hyo-Jin,Choo Eun Ju,Baek Ji Hyeon,Chin Bum Sik,Kim Woo Joo,Lee Mi Suk,Park Wan Beom,Han Sang Hoon,Choi Jun Yong,Yeom Joon-Sup,Lee Jin-Soo,Choi Hee-Jung,Cho 대한감염학회 2024 Infection and Chemotherapy Vol.56 No.2
The Korean Society of Infectious Diseases has been regularly developing guidelines for adult immunization since 2007. In 2023, the guidelines for the following seven vaccines were revised: influenza, herpes zoster, pneumococcal, tetanus-diphtheria-pertussis (Tdap), human papillomavirus (HPV), meningococcal, and rabies vaccines. For the influenza vaccine, a recommendation for enhanced vaccines for the elderly was added. For the herpes zoster vaccine, a recommendation for the recombinant zoster vaccine was added. For the pneumococcal vaccine, the current status of the 15-valent pneumococcal conjugate vaccine and 20-valent PCV was described. For the Tdap vaccine, the possibility of using Tdap instead of tetanus-diphtheria vaccine was described. For the HPV vaccine, the expansion of the eligible age for vaccination was described. For the meningococcal vaccine, a recommendation for the meningococcal B vaccine was added. For the rabies vaccine, the number of pre-exposure prophylaxis doses was changed. This manuscript documents the summary and rationale of the revisions for the seven vaccines. For the vaccines not mentioned in this manuscript, the recommendations in the 3rd edition of the Vaccinations for Adults textbook shall remain in effect.